R HERTZBERG 13G

Company

Cellectar Biosciences, Inc.

Filed

June 2, 2016

Accession Number

0001676051-16-000002

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →